-+ 0.00%
-+ 0.00%
-+ 0.00%

Valion Bio Completes 200-Liter Entolimod Production Run

PUBT·11/17/2026 13:28:50
Listen to the news
Valion Bio Completes 200-Liter Entolimod Production Run
  • Valion Bio completed a 200-liter non-GMP Entolimod production run at subsidiary Velocity Bioworks in May-June 2026.
  • Productivity rose approximately 27% versus historical manufacturing data; the resulting drug substance met all predefined acceptance criteria for assessed quality attributes.
  • The run increased production scale fourfold from a 50-liter run completed in January 2026.
  • Drug product filled in June is supplying the ongoing AFRRI Entolimod study, fully funded by NIAID’s Radiation and Nuclear Countermeasures Program.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valion Bio Inc. published the original content used to generate this news brief on November 17, 2026, and is solely responsible for the information contained therein.